Primary Care Services Information Systems (SISAP), Institut Català de La Salut (ICS), Gran Via de Les Corts Catalanes, 587. 08007, Barcelona, Spain.
Gotic Primary Care Centre, Institut Català de La Salut (ICS), Barcelona, Spain.
BMC Prim Care. 2024 May 4;25(1):150. doi: 10.1186/s12875-024-02395-4.
The aim of our study is to analyse the trends in the diagnosis of sexually transmitted infections (STIs) during the COVID-19 pandemic.
We conducted an observational retrospective population-based study using data from primary care electronic health records spanning from January 2016 to December 2022 (involving 5.1 million people older than 14 years). We described the daily number of new STI diagnoses from 2016 to 2022; as well as the monthly accumulation of new STI diagnoses for each year. We compared the monthly averages of new diagnoses in 2019, 2020, 2021 and 2022 using the T-test. Finally, we performed a segmented regression analysis of the daily number of STI diagnoses.
We analysed 200,676 new STI diagnoses. The number of diagnoses abruptly decreased coinciding with the lockdown. Overall in 2020, we observed a reduction of 15%, with higher reductions for specific STIs such as gonorrhoea (-21%), chlamydia (-24%), and HIV (-31%) compared to 2019. Following this drastic drop, which was temporarily associated with the lockdown, we observed a rapid rebound. In 2021, the number of STI diagnoses was similar to that of 2019. Notably, we found a considerable increase in 2022, particularly for non-specific STI, which lack laboratory confirmation (67% increase). HIV was the only STI with a reduction of up to -38% in diagnoses at the end of 2022 compared to 2019.
After a significant reduction in 2020, the number of STIs recorded in primary care rapidly rebounded, and the current trend is similar to that of 2019, except for HIV. These findings underscore the dynamic impact of the COVID-19 pandemic on STI diagnoses and highlight the importance of ongoing monitoring and public health interventions in the post-pandemic period.
本研究旨在分析 COVID-19 大流行期间性传播感染(STI)诊断趋势。
我们使用初级保健电子健康记录中的数据进行了一项观察性回顾性基于人群的研究,该记录涵盖 2016 年 1 月至 2022 年 12 月(涉及 14 岁以上的 510 万人)。我们描述了 2016 年至 2022 年新 STI 诊断的每日数量;以及每年新 STI 诊断的每月累积量。我们使用 T 检验比较了 2019 年、2020 年、2021 年和 2022 年每月新诊断的平均值。最后,我们对每日 STI 诊断数量进行了分段回归分析。
我们分析了 200,676 例新的 STI 诊断。诊断数量急剧下降,与封锁同步。总体而言,2020 年我们观察到减少了 15%,淋病(-21%)、衣原体(-24%)和 HIV(-31%)等特定 STI 的减少幅度更高,与 2019 年相比。在与封锁相关的这种急剧下降之后,我们观察到了快速反弹。2021 年,STI 的数量与 2019 年相似。值得注意的是,我们发现 2022 年的数量显著增加,特别是对于缺乏实验室确认的非特定 STI(增加了 67%)。HIV 是唯一一种 2022 年诊断数量与 2019 年相比减少了 38%的 STI。
2020 年大幅减少后,初级保健中记录的 STI 数量迅速反弹,目前的趋势与 2019 年相似,除了 HIV。这些发现强调了 COVID-19 大流行对 STI 诊断的动态影响,并突出了在大流行后时期进行持续监测和公共卫生干预的重要性。